← Leaderboards
Hannah Rabinowich
University Of Pittsburgh At Pittsburgh
$5,303,204
Attributed
$5,303,204
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $587.9K · FY2005–20$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$5,303,204 · 6
VA$0 · 1
By mechanism
R01$4,788,673 · 4
R21$368,445 · 1
P01$146,086 · 1
I01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Dario Aa Vignali$40,087,127
- Robert L Ferris$24,076,317
- Hassane M Zarour$16,372,397
- Lawrence P Kane$11,819,892
- Raja R. Seethala$1,774,592
Others in their field
Top investigators on “Apoptosis”
- David Heimbrook · Leidos Biomedical Research, Inc.$49,205,802
- Jay A Nelson · Oregon Health & Science University$45,942,124
- John C Reed · University Of Texas Md Anderson Can Ctr$34,437,189
- John A Tainer · Scripps Research Institute$30,637,655
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$28,872,594
- John D Minna · University Of Texas Sw Med Ctr/Dallas$27,317,167
Research focus
ApoptosisNeoplastic CellResistanceTumorRegulationResponseApoptoticCellsBaseRepressionCell DeathMolecularDesignCell SurvivalReportingPredispositionCancer CellResearch DesignAutophagosomeAutophagocytosisCytotoxicMutationCessation Of LifeProteins
Grant awards (27)
Sensitization of lung cancer to EGFR tyrosine kinase inhibitors$0
I01 · FY2020 · VA · contact PI
Sensitization of lung cancer to EGFR tyrosine kinase inhibitors$0
I01 · FY2019 · VA · contact PI
Sensitization of lung cancer to EGFR tyrosine kinase inhibitors$0
I01 · FY2018 · VA · contact PI
Sensitization of lung cancer to EGFR tyrosine kinase inhibitors$0
I01 · FY2017 · VA · contact PI
Molecular determinants in autophagic repression of intrinsic apoptosis$167,475
R21 · FY2016 · CA · contact PI
Sensitization of lung cancer to EGFR tyrosine kinase inhibitors$0
I01 · FY2016 · VA · contact PI
Molecular determinants in autophagic repression of intrinsic apoptosis$200,970
R21 · FY2015 · CA · contact PI
Sensitization of lung cancer to EGFR tyrosine kinase inhibitors$0
I01 · FY2015 · VA · contact PI
Cross-regulation of apoptosis and autophagy as a molecular basis for reversal of$302,201
R01 · FY2012 · CA · contact PI
Cross-regulation of apoptosis and autophagy as a molecular basis for reversal of$302,281
R01 · FY2011 · CA · contact PI
Cross-regulation of apoptosis and autophagy as a molecular basis for reversal of$311,712
R01 · FY2010 · CA · contact PI
Cross-regulation of apoptosis and autophagy as a molecular basis for reversal of$311,788
R01 · FY2009 · CA · contact PI
Novel Targets for Protection of T Cells From Tumor-Induced Dysfunction$267,772
R01 · FY2009 · CA · contact PI
New Pathways in Lymphocyte Granule-Mediated Cytotoxicity$288,651
R01 · FY2008 · CA · contact PI
Novel Targets for Protection of T Cells From Tumor-Induced Dysfunction$268,039
R01 · FY2008 · CA · contact PI
New Pathways in Lymphocyte Granule-Mediated Cytotoxicity$288,651
R01 · FY2007 · CA · contact PI
Novel Targets for Protection of T Cells From Tumor-Induced Dysfunction$268,298
R01 · FY2007 · CA · contact PI
New Pathways in Lymphocyte Granule-Mediated Cytotoxicity$297,272
R01 · FY2006 · CA · contact PI
Novel Targets for Protection of T Cells From Tumor-Induced Dysfunction$276,569
R01 · FY2006 · CA · contact PI
New Pathways in Lymphocyte Granule-Mediated Cytotoxicity$304,425
R01 · FY2005 · CA
Novel Targets/Protection of T Cells From Tumor-Induced$283,483
R01 · FY2005 · CA
New Pathways in Lymphocyte Granule-Mediated Cytotoxicity$304,425
R01 · FY2004 · CA
THERAPEUTIC APPROACH TO PROTECT T CELLS FROM APOPTOSIS$240,931
R01 · FY2002 · CA
THERAPEUTIC APPROACH TO PROTECT T CELLS FROM APOPTOSIS$239,576
R01 · FY2001 · CA
ORAL CARCINOMA--SIGNAL TRANSDUCTION IN LYMPHOCYTES$73,043
P01 · FY2001 · DE
THERAPEUTIC APPROACH TO PROTECT T CELLS FROM APOPTOSIS$232,599
R01 · FY2000 · CA
ORAL CARCINOMA--SIGNAL TRANSDUCTION IN LYMPHOCYTES$73,043
P01 · FY2000 · DE